Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on SSS17 PK in Healthy Chinese Subjects
NCT07024888Phase 1Completed
- Sponsor
- 3SBio
- Start
- Mar 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of SSS-17 in anemia of chronic kidney disease (CKD-A) (3 arms), sponsored by 3SBio. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Mar 2025; status: completed.
02
Drugs
SSS-17
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT07024888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07024888.